Browsing Öksüz Yayınlar Koleksiyonu - WoS by Author "Parissis, John T."
Now showing items 1-2 of 2
-
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan
Papp, Zoltan; Edes, Istvan; Fruhwald, Sonja; De Hert, Stefan G.; Salmenpera, Markku; Leppikangas, Heli; Mebazaa, Alexandre; Landoni, Giovanni; Grossini, Elena; Caimmi, Philippe; Morelli, Andrea; Guarracino, Fabio; Schwinger, Robert H. G.; Meyer, Sven; Algotsson, Lars; Wikstrom, Bernt Gerhard; Jorgensen, Kirsten; Filippatos, Gerasimos; Parissis, John T.; Garcia Gonzalez, Martin J.; Parkhomenko, Alexander; Yilmaz, Mehmet Birhan; Kivikko, Matti; Pollesello, Piero; Follath, Ferenc (ELSEVIER IRELAND LTD, 2012)The molecular background of the Ca2+-sensitizing effect of levosimendan relates to its specific interaction with the Ca2+-sensor troponin C molecule in the cardiac myofilaments. Over the years, significant preclinical and ... -
Renal Effects of Levosimendan: A Consensus Report
Yilmaz, Mehmet B.; Grossini, Elena; Silva Cardoso, Jose C.; Edes, Istvan; Fedele, Francesco; Pollesello, Piero; Kivikko, Matti; Harjola, Veli-Pekka; Hasslacher, Julia; Mebazaa, Alexandre; Morelli, Andrea; le Noble, Jos; Oldner, Anders; Oulego Erroz, Ignacio; Parissis, John T.; Parkhomenko, Alexander; Poelzl, Gerhard; Rehberg, Sebastian; Ricksten, Sven-Erik; Rodriguez Fernandez, Luis M.; Salmenpera, Markku; Singer, Mervyn; Treskatsch, Sascha; Vrtovec, Bojan; Wikstrom, Gerhard (SPRINGER, 2013)Renal dysfunction is common in clinical settings in which cardiac function is compromised such as heart failure, cardiac surgery or sepsis, and is associated with high morbidity and mortality. Levosimendan is a calcium ...